{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:43:10Z","timestamp":1786984990253,"version":"build-2736575974"},"reference-count":293,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005624","name":"Medizinischen Hochschule Hannover","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["521990259"],"award-info":[{"award-number":["521990259"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bbamcr.2026.120113","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:22:00Z","timestamp":1768807320000},"page":"120113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Friend or foe: New cytokine players in beta cell failure in type 1 diabetes mellitus"],"prefix":"10.1016","volume":"1873","author":[{"given":"Ewa","family":"Gurgul-Convey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ortwin","family":"Naujok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.bbamcr.2026.120113_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.16501","article-title":"The changing epidemiology of type 1 diabetes: a global perspective","volume":"27","author":"Bell","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0010","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 diabetes mellitus","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat Revs. Disease primers"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0015","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/iub.1330","article-title":"Islet inflammation in human type 1 diabetes mellitus","volume":"66","author":"Morgan","year":"2014","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0020","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1007\/s10753-025-02303-7","article-title":"From homeostasis to inflammation to autoimmunity: the potential impact of CRP","volume":"48","author":"Ahmed","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2009.21","article-title":"The role of inflammation in insulitis and beta-cell loss in type 1 diabetes","volume":"5","author":"Eizirik","year":"2009","journal-title":"Nat Rev. Endocrinology"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0030","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.coi.2011.10.001","article-title":"Diabetogenic T lymphocytes in human type 1 diabetes","volume":"23","author":"Roep","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00003.2010","article-title":"Type 1 diabetes: etiology, immunology, and therapeutic strategies","volume":"91","author":"van Belle","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0040","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.2337\/db12-1398","article-title":"Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms","volume":"62","author":"Nguyen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0045","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","article-title":"Genetic risk factors for type 1 diabetes","volume":"387","author":"Pociot","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0050","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00109-020-01941-8","article-title":"Translation of curative therapy concepts with T cell and cytokine antibody combinations for type 1 diabetes reversal in the IDDM rat","volume":"98","author":"J\u00f6rns","year":"2020","journal-title":"J. Mol. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.bbamcr.2026.120113_bb0055","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/diabetes.54.suppl_2.S97","article-title":"Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities","volume":"54","author":"Cnop","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0060","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s001250100021","article-title":"A choice of death-the signal-transduction of immune-mediated beta-cell apoptosis","volume":"44","author":"Eizirik","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0065","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/s41588-019-0524-6","article-title":"The impact of proinflammatory cytokines on the beta-cell regulatory landscape provides insights into the genetics of type 1 diabetes","volume":"51","author":"Ramos-Rodriguez","year":"2019","journal-title":"Nat Gen"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4734063","article-title":"Interleukin-6 and interleukin-15 as possible biomarkers of the risk of autoimmune diabetes development","volume":"2019","author":"Siewko","year":"2019","journal-title":"BioMed Res Internat"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/MI\/2006\/59206","article-title":"Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children","volume":"2006","author":"Dogan","year":"2006","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0080","doi-asserted-by":"crossref","first-page":"E1179","DOI":"10.1210\/JC.2015-1388","article-title":"Large-scale discovery and validation studies demonstrate significant reductions in circulating levels of IL8, IL-1Ra, MCP-1, and MIP-1beta in patients with type 1 diabetes","volume":"100","author":"Purohit","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0085","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41390-021-01569-5","article-title":"Genetic polymorphism of interleukin-1 receptor antagonist in type 1 diabetic children","volume":"91","author":"Abed","year":"2022","journal-title":"Pediatric Res"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0090","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00125-013-2896-y","article-title":"Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children","volume":"56","author":"Achenbach","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.6065\/apem.2346178.089","article-title":"Impacts of circulating cytokine levels and gene polymorphism predisposition on type 1 diabetes mellitus","volume":"29","author":"Alghamdi","year":"2024","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2979846","article-title":"Interleukin-17A gene variability in patients with type 1 diabetes mellitus and chronic periodontitis: its correlation with IL-17 levels and the occurrence of Periodontopathic Bacteria","volume":"2016","author":"Borilova Linhartova","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0105","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s00125-024-06267-5","article-title":"Genetic evidence for efficacy of targeting IL-2, IL-6 and TYK2 signalling in the prevention of type 1 diabetes: a Mendelian randomisation study","volume":"67","author":"Heikkila","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0110","first-page":"277","article-title":"Association between interleukin-6 polymorphism and age-at-onset of type 1 diabetes. Epistatic influences of the tumor necrosis factor-alpha and interleukin-1beta polymorphisms, Eur Cyt","volume":"16","author":"Hermann","year":"2005","journal-title":"Network"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/iji.12535","article-title":"Association of single-nucleotide polymorphisms in tumour necrosis factor and human leukocyte antigens genes with type 1 diabetes","volume":"48","author":"Osman","year":"2021","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0120","doi-asserted-by":"crossref","DOI":"10.1177\/03946320221090330","article-title":"Single nucleotide polymorphism rs 2070874 at Interleukin-4 is associated with increased risk of type 1 diabetes mellitus independently of human leukocyte antigens","volume":"36","author":"Osman","year":"2022","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0125","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.humimm.2004.09.001","article-title":"Alleles of the IL12B 3\u2019UTR associate with late onset of type 1 diabetes","volume":"65","author":"Windsor","year":"2004","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0130","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0135","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0140","first-page":"396","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"2010","author":"Kim","year":"1802","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0145","article-title":"Interferon signaling in cancer","volume":"43","author":"Saleiro","year":"2019","journal-title":"Non-canonical pathways and control of intracellular immune checkpoints, Seminars in immunology"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0150","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00125-013-3125-4","article-title":"Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes","volume":"57","author":"J\u00f6rns","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138034","article-title":"Lipid mediators and biomarkers associated with type 1 diabetes development","volume":"5","author":"Nelson","year":"2020","journal-title":"JCI insight"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081835","article-title":"Sphingolipids in type 1 diabetes: focus on Beta-cells","volume":"9","author":"Gurgul-Convey","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0165","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1210\/en.2013-2134","article-title":"Evidence of contribution of iPLA2beta-mediated events during islet beta-cell apoptosis due to proinflammatory cytokines suggests a role for iPLA2beta in T1D development","volume":"155","author":"Lei","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1444639","article-title":"Differential lipid signaling from CD4(+) and CD8(+) T cells contributes to type 1 diabetes development","volume":"15","author":"White","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mito.2023.07.002","article-title":"Type 1 diabetes mellitus: inflammation, mitophagy, and mitochondrial function","volume":"72","author":"Blagov","year":"2023","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0180","first-page":"1929","article-title":"Chemistry and biology of reactive species with special reference to the antioxidative defence status in pancreatic beta-cells","volume":"2017","author":"Lenzen","year":"1861","journal-title":"Biochim Biophys Acta. General subjects"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0185","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1007\/s00125-005-0039-9","article-title":"Extracellular signal-regulated kinase is essential for interleukin-1-induced and nuclear factor kappaB-mediated gene expression in insulin-producing INS-1E cells","volume":"48","author":"Larsen","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0190","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1006\/bbrc.2001.4361","article-title":"Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase","volume":"281","author":"Andersson","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0195","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2337\/db18-0073","article-title":"The no-go and nonsense-mediated RNA decay pathways are regulated by inflammatory cytokines in insulin-producing cells and human islets and determine beta-cell insulin biosynthesis and survival","volume":"67","author":"Ghiasi","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0200","doi-asserted-by":"crossref","first-page":"20292","DOI":"10.1074\/jbc.M117.814491","article-title":"Overexpression of sphingosine-1-phosphate lyase protects insulin-secreting cells against cytokine toxicity","volume":"292","author":"Hahn","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41419-018-1268-4","article-title":"MCPIP1 regulates the sensitivity of pancreatic beta-cells to cytokine toxicity","volume":"10","author":"Tyka","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166199","article-title":"MCPIP1 is a novel link between diabetogenic conditions and impaired insulin secretory capacity, Biochim Biophys Acta","volume":"1867","author":"Tyka","year":"2021","journal-title":"Molecular basis of disease"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0215","doi-asserted-by":"crossref","first-page":"C1581","DOI":"10.1152\/ajpcell.1996.270.6.C1581","article-title":"Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets","volume":"270","author":"Corbett","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0220","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2337\/diabetes.47.9.1379","article-title":"Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis","volume":"47","author":"Robertson","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0225","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0006-2952(01)00605-0","article-title":"Role of p38 mitogen-activated protein kinase (p38 MAPK) in cytokine-induced rat islet cell apoptosis","volume":"61","author":"Saldeen","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0230","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00125-022-05654-0","article-title":"Proinflammatory cytokines induce rapid, NO-independent apoptosis, expression of chemotactic mediators and interleukin-32 secretion in human pluripotent stem cell-derived beta cells","volume":"65","author":"Dettmer","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0235","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mce.2018.08.001","article-title":"Regulation of the beta-cell inflammasome and contribution to stress-induced cellular dysfunction and apoptosis","volume":"478","author":"Ghiasi","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0240","doi-asserted-by":"crossref","first-page":"11121","DOI":"10.1074\/jbc.M109.054775","article-title":"Protection against cytokine toxicity through endoplasmic reticulum and mitochondrial stress prevention by prostacyclin synthase overexpression in insulin-producing cells","volume":"285","author":"Gurgul-Convey","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0245","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cyto.2011.04.002","article-title":"Differential effects of proinflammatory cytokines on cell death and ER stress in insulin-secreting INS1E cells and the involvement of nitric oxide","volume":"55","author":"Kacheva","year":"2011","journal-title":"Cytokine"},{"issue":"Suppl. 2","key":"10.1016\/j.bbamcr.2026.120113_bb0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/dom.13388","article-title":"When one becomes many-alternative splicing in beta-cell function and failure","volume":"20","author":"Alvelos","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0255","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00125-012-2762-3","article-title":"Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation","volume":"56","author":"Eizirik","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0260","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/cdd.2012.67","article-title":"C\/EBP homologous protein contributes to cytokine-induced pro-inflammatory responses and apoptosis in beta-cells","volume":"19","author":"Allagnat","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/cells11101623","article-title":"Characterization of peripheral blood TCR in patients with type 1 diabetes mellitus by BD rhapsody(TM) VDJ CDR3 assay","volume":"11","author":"Okamura","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0270","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13012","article-title":"The role of Interleukin-32 in autoimmunity","volume":"93","author":"de Albuquerque","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0275","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00109-011-0747-1","article-title":"Cytokine toxicity in insulin-producing cells is mediated by nitro-oxidative stress-induced hydroxyl radical formation in mitochondria","volume":"89","author":"Gurgul-Convey","year":"2011","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0280","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/diabetes.53.9.2271","article-title":"Mitochondrial catalase overexpression protects insulin-producing cells against toxicity of reactive oxygen species and proinflammatory cytokines","volume":"53","author":"Gurgul","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0285","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1677\/JOE-07-0638","article-title":"Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells","volume":"197","author":"Souza","year":"2008","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0290","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2249.2007.03375.x","article-title":"Pre-incubation with interleukin-4 mediates a direct protective effect against the loss of pancreatic beta-cell viability induced by proinflammatory cytokines","volume":"148","author":"Kaminski","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0295","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/BSR20090021","article-title":"Human and rodent pancreatic beta-cells express IL-4 receptors and IL-4 protects against beta-cell apoptosis by activation of the PI3K and JAK\/STAT pathways","volume":"30","author":"Kaminski","year":"2009","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0300","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00125-018-4750-8","article-title":"The transcription factor STAT6 plays a critical role in promoting beta cell viability and is depleted in islets of individuals with type 1 diabetes","volume":"62","author":"Leslie","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0305","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4161\/isl.24249","article-title":"Differential effects of interleukin-13 and interleukin-6 on Jak\/STAT signaling and cell viability in pancreatic beta-cells","volume":"5","author":"Russell","year":"2013","journal-title":"Islets"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0310","doi-asserted-by":"crossref","DOI":"10.4161\/19382014.2014.950547","article-title":"The impact of anti-inflammatory cytokines on the pancreatic beta-cell","volume":"6","author":"Russell","year":"2014","journal-title":"Islets"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0315","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.2337\/diabetes.48.8.1522","article-title":"Interleukin-13 prevents autoimmune diabetes in NOD mice","volume":"48","author":"Zaccone","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0320","doi-asserted-by":"crossref","first-page":"12191","DOI":"10.1073\/pnas.211445998","article-title":"Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity","volume":"98","author":"Karlsen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0325","doi-asserted-by":"crossref","first-page":"53145","DOI":"10.1074\/jbc.M410978200","article-title":"Role of cyclooxygenase-2 in cytokine-induced beta-cell dysfunction and damage by isolated rat and human islets","volume":"279","author":"Heitmeier","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0330","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00125-008-1090-0","article-title":"Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection","volume":"51","author":"Ronn","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0335","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00125-016-4060-y","article-title":"Sensitivity profile of the human EndoC-betaH1 beta cell line to proinflammatory cytokines","volume":"59","author":"Gurgul-Convey","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0340","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/1043-4666(91)90031-8","article-title":"Species differences in human and rat islet sensitivity to human cytokines. Monoclonal anti-interleukin-1 (IL-1) influences on direct and indirect IL-1-mediated islet effects","volume":"3","author":"Kawahara","year":"1991","journal-title":"Cytokine"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0345","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00125-015-3669-6","article-title":"Cytokines induce endoplasmic reticulum stress in human, rat and mouse beta cells via different mechanisms","volume":"58","author":"Brozzi","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0350","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/JOE-17-0110","article-title":"The immunoproteasome is induced by cytokines and regulates apoptosis in human islets","volume":"233","author":"Lundh","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0355","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/db24-1122","article-title":"Autoreactive T cells and cytokine stress drive beta-cell senescence entry and accumulation in type 1 diabetes","volume":"74","author":"Pipella","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0360","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molimm.2014.12.012","article-title":"Increased expression of IL-18 in the serum and islets of type 1 diabetics","volume":"64","author":"Harms","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0365","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cyto.2016.07.007","article-title":"Increased serum levels of novel T cell cytokines IL-33, IL-9 and IL-17 in subjects with type-1 diabetes","volume":"86","author":"Shruthi","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0370","doi-asserted-by":"crossref","first-page":"24225","DOI":"10.1038\/s41598-024-73737-6","article-title":"Clinical importance of cytokine (IL-6, IL-8, and IL-10) and vitamin D levels among patients with Type-1 diabetes","volume":"14","author":"Syed Khaja","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0375","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.2337\/db19-0287","article-title":"Early detection of peripheral blood cell signature in children developing beta-cell autoimmunity at a young age","volume":"68","author":"Kallionpaa","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0380","doi-asserted-by":"crossref","DOI":"10.1177\/03946320231209821","article-title":"Correlation analysis between cytokines\u2019 profile, autoimmune antibodies and the duration of type 1 diabetes: A case control study in a specialized children\u2019s Centre in Riyadh","volume":"37","author":"Al-Dubayee","year":"2023","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161548","article-title":"Role of pro-inflammatory cytokines and biochemical markers in the pathogenesis of type 1 diabetes: correlation with age and glycemic condition in diabetic human subjects","volume":"11","author":"Fatima","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0390","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imr.12615","article-title":"Function and regulation of IL-1alpha in inflammatory diseases and cancer","volume":"281","author":"Malik","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101140","article-title":"Pancreatic, but not myeloid-cell, expression of interleukin-1alpha is required for maintenance of insulin secretion and whole body glucose homeostasis","volume":"44","author":"Collier","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0400","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2337\/db19-0865","article-title":"Pancreas pathology of latent autoimmune diabetes in adults (LADA) in patients and in a LADA rat model compared with type 1 diabetes","volume":"69","author":"J\u00f6rns","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0405","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2337\/db12-0397","article-title":"On the immense variety and complexity of circumstances conditioning pancreatic beta-cell apoptosis in type 1 diabetes","volume":"61","author":"Eizirik","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0410","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.2337\/diabetes.50.12.2721","article-title":"Interleukin-1beta stimulation of c-Jun NH(2)-terminal kinase activity in insulin-secreting cells: evidence for cytoplasmic restriction","volume":"50","author":"Major","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0415","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/diabetes.53.1.113","article-title":"IL-1 receptor deficiency slows progression to diabetes in the NOD mouse","volume":"53","author":"Thomas","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0420","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/jsre.2001.6285","article-title":"Cytokine-induced metabolic dysfunction of MIN6 beta cells is nitric oxide independent","volume":"101","author":"Wu","year":"2001","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0425","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/abbs\/37.2.139","article-title":"Potential role of NO in modulation of COX-2 expression and PGE2 production in pancreatic beta-cells","volume":"37","author":"Ling","year":"2005","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0430","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41419-025-08059-0","article-title":"IL-1beta priming triggers an adaptive stress response that enhances pancreatic beta-cell resilience to subsequent cytotoxic inflammatory insult","volume":"16","author":"Setula","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0435","first-page":"E664","article-title":"SUMOylation protects against IL-1beta-induced apoptosis in INS-1 832\/13 cells and human islets, American journal of physiology","volume":"307","author":"Hajmrle","year":"2014","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0440","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1128523","article-title":"Characterization of the functional and transcriptomic effects of pro-inflammatory cytokines on human EndoC-betaH5 beta cells","volume":"14","author":"Fr\u00f8rup","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0445","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1172\/JCI117188","article-title":"Cytokines suppress human islet function irrespective of their effects on nitric oxide generation","volume":"93","author":"Eizirik","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002552","article-title":"The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines","volume":"8","author":"Eizirik","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0455","first-page":"399","article-title":"Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets","volume":"76","author":"Eizirik","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0460","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86055","article-title":"Interleukin-1 signaling contributes to acute islet compensation","volume":"1","author":"Hajmrle","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0465","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00109-024-02494-w","article-title":"Therapy concepts in type 1 diabetes mellitus treatment: disease modifying versus curative approaches","volume":"102","author":"Lenzen","year":"2024","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0470","first-page":"743","article-title":"Anti-TCR therapy combined with fingolimod for reversal of diabetic hyperglycemia by beta cell regeneration in the LEW.1AR1-iddm rat model of type 1 diabetes","volume":"92","author":"J\u00f6rns","year":"2014","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0475","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.2337\/db14-1866","article-title":"TNF-alpha antibody therapy in combination with the T-cell-specific antibody anti-TCR reverses the diabetic metabolic state in the LEW.1AR1-iddm rat","volume":"64","author":"J\u00f6rns","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0480","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-2094-11-27","article-title":"Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist","volume":"11","author":"Klementiev","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0485","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1006\/bbrc.1994.1962","article-title":"Interleukin-1 receptor antagonist prevents low dose streptozotocin induced diabetes in mice","volume":"202","author":"Sandberg","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0490","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.gt.3302351","article-title":"Adenoviral overexpression of interleukin-1 receptor antagonist protein increases beta-cell replication in rat pancreatic islets","volume":"12","author":"Tellez","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0495","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2337\/diabetes.48.9.1730","article-title":"Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1beta-induced beta-cell impairment and activation of islet cell apoptosis in vitro","volume":"48","author":"Giannoukakis","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0500","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.imlet.2004.08.016","article-title":"Interleukin IL-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults","volume":"96","author":"Novota","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0505","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000057959","article-title":"Functional IL-18 is produced by primary pancreatic mouse islets and NIT-1 beta cells and participates in the progression towards destructive insulitis","volume":"57","author":"Frigerio","year":"2002","journal-title":"Hormone Res"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0510","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jaut.2011.02.005","article-title":"IL-18 is required for self-reactive T cell expansion in NOD mice","volume":"36","author":"Marleau","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0515","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4049\/jimmunol.163.3.1230","article-title":"IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis","volume":"163","author":"Rothe","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0520","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.4049\/jimmunol.171.11.5865","article-title":"Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice","volume":"171","author":"Oikawa","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176059","article-title":"IL-33 promotes pancreatic beta-cell survival and insulin secretion under diabetogenic conditions through PPARgamma","volume":"959","author":"Lin","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0530","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.intimp.2019.02.018","article-title":"Interleukin-33 prevents the development of autoimmune diabetes in NOD mice","volume":"70","author":"Lu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0535","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.3389\/fimmu.2018.02646","article-title":"IL-33 prevents MLD-STZ induction of diabetes and attenuate insulitis in Prediabetic NOD mice","volume":"9","author":"Pavlovic","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0540","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2019.03.028","article-title":"The gamma(c) family of cytokines: basic biology to therapeutic ramifications","volume":"50","author":"Leonard","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0545","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.immunol.26.021607.090357","article-title":"The biology of interleukin-2","volume":"26","author":"Malek","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0550","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0555","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/imr.13230","article-title":"Engineering the IL-4\/IL-13 axis for targeted immune modulation","volume":"320","author":"Bernstein","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0560","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41419-021-03769-7","article-title":"IL-4 inhibits regulatory T cells differentiation by HDAC9-mediated epigenetic regulation","volume":"12","author":"Cui","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0565","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/1873-3468.14305","article-title":"Soluble forms of cytokine and growth factor receptors: mechanisms of generation and modes of action in the regulation of local and systemic inflammation","volume":"596","author":"Kefaloyianni","year":"2022","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0570","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.humimm.2016.12.010","article-title":"Th9 cells and IL-9 in autoimmune disorders: pathogenesis and therapeutic potentials","volume":"78","author":"Deng","year":"2017","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0575","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.2337\/db13-0669","article-title":"beta-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice","volume":"62","author":"Johnson","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0580","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/gt.2014.45","article-title":"Expression of IL-2 in beta cells by AAV8 gene transfer in pre-diabetic NOD mice prevents diabetes through activation of FoxP3-positive regulatory T cells","volume":"21","author":"Flores","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0585","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.2337\/db20-0186","article-title":"Persistent IL-2 receptor signaling by IL-2\/CD25 fusion protein controls diabetes in NOD mice by multiple mechanisms","volume":"69","author":"Ward","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0590","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.182064","article-title":"The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes","volume":"9","author":"Alvarez","year":"2024","journal-title":"JCI insight"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0595","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00125-020-05200-w","article-title":"Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a phase I\/II randomised, double-blind, placebo-controlled, dose-finding study","volume":"63","author":"Rosenzwajg","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0600","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/icb.2017.49","article-title":"CD11a\/ICAM-1 blockade combined with IL-2 targeting therapy causes a paradoxical acceleration of type 1 diabetes","volume":"95","author":"Brenu","year":"2017","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0605","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/intimm\/6.11.1629","article-title":"Transgenic mice expressing constitutive levels of IL-2 in islet beta cells develop diabetes","volume":"6","author":"Elliott","year":"1994","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0610","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1210\/en.2002-220583","article-title":"Effect of proinflammatory cytokines on gene expression of the diabetes-associated autoantigen IA-2 in INS-1 cells","volume":"143","author":"Steinbrenner","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0615","first-page":"14","article-title":"Nitric oxide production by the rat insulinoma cell line, RINm5F, is specific for IL-1: a spectrophotometric IL-1 bioassay","volume":"236","author":"Hill","year":"1996","journal-title":"AnalytBiochem"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0620","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1084\/jem.178.1.87","article-title":"Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice","volume":"178","author":"Rapoport","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0625","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/clin.1994.1068","article-title":"Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse","volume":"71","author":"Pennline","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0630","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.4049\/jimmunol.159.10.4686","article-title":"IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function","volume":"159","author":"Cameron","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0635","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/jcb.10250","article-title":"Th1 and Th2 cytokines exert regulatory effects upon islet microvascular areas in the NOD mouse","volume":"86","author":"Papaccio","year":"2002","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0640","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/mt.2008.116","article-title":"AAV8-mediated gene transfer of interleukin-4 to endogenous beta-cells prevents the onset of diabetes in NOD mice","volume":"16","author":"Rehman","year":"2008","journal-title":"Mol Ther: J Am Soc Gen Ther"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0645","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1210\/jcem.86.10.7938","article-title":"Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines","volume":"86","author":"Marselli","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0650","article-title":"Recombinant Lactococcus lactis carrying IL-4 and IL-10 coding vectors protects against type 1 diabetes in NOD mice and attenuates insulitis in the STZ-induced model","volume":"2021","author":"Preisser","year":"2021","journal-title":"J Diab Res"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0655","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00125-002-1017-0","article-title":"IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice","volume":"46","author":"Cardozo","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0660","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2002-19959","article-title":"Immunoregulation during disease progression in prediabetic NOD mice: inverse expression of arginase and prostaglandin H synthase 2 vs. interleukin-15","volume":"34","author":"Rothe","year":"2002","journal-title":"Horm Metab rRes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0665","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.diabres.2005.02.007","article-title":"IL-15 is elevated in serum patients with type 1 diabetes mellitus","volume":"69","author":"Kuczynski","year":"2005","journal-title":"Diab Res Clin Pract"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0670","doi-asserted-by":"crossref","first-page":"13534","DOI":"10.1073\/pnas.1312911110","article-title":"Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Ralpha","volume":"110","author":"Chen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0675","doi-asserted-by":"crossref","first-page":"13074","DOI":"10.1073\/pnas.0705863104","article-title":"Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts","volume":"104","author":"Koulmanda","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0680","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41577-023-00856-y","article-title":"Targeting IL-6 trans-signalling: past, present and future prospects","volume":"23","author":"Rose-John","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0685","first-page":"2105","article-title":"Proteolytic control of Interleukin-11 and Interleukin-6 biology","volume":"2017","author":"Lokau","year":"1864","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0690","first-page":"207","article-title":"Dissecting Interleukin-6 classic and trans-signaling in inflammation and Cancer, meth","volume":"2691","author":"Garbers","year":"2023","journal-title":"Mol. Biol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0695","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.4049\/jimmunol.2100882","article-title":"IL-6 signaling attenuates TNF-alpha production by plasmacytoid dendritic cells in rheumatoid arthritis","volume":"209","author":"Papadaki","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0700","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000289196","article-title":"Transcriptional control of the TNF gene","volume":"11","author":"Falvo","year":"2010","journal-title":"Curr Direct Autoimmun"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0705","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11892-016-0807-6","article-title":"Restoring regulatory T cells in type 1 diabetes","volume":"16","author":"Spence","year":"2016","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0710","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1182\/blood.V97.9.2758","article-title":"Interleukin-11 induces Th2 polarization of human CD4(+) T cells","volume":"97","author":"Curti","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0715","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41586-024-07701-9","article-title":"Inhibition of IL-11 signalling extends mammalian healthspan and lifespan","volume":"632","author":"Widjaja","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0720","article-title":"Interleukin-27 in tuberculosis: A sheep in Wolf\u2019s clothing?","volume":"12","author":"Ritter","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0725","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.713001","article-title":"Integrative characterization of the role of IL27 in melanoma using bioinformatics analysis","volume":"12","author":"Dong","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0730","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1074\/jbc.M112.432955","article-title":"An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer","volume":"288","author":"Garbers","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0735","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ni.3632","article-title":"Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic T(H)17 cells","volume":"18","author":"Heink","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0740","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41598-020-57507-8","article-title":"Enhanced STAT3 phosphorylation and PD-L1 expression in myeloid dendritic cells indicate impaired IL-27Ralpha signaling in type 1 diabetes","volume":"10","author":"Parackova","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0745","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/intimm\/6.12.1829","article-title":"Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice","volume":"6","author":"DiCosmo","year":"1994","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108320","article-title":"IL-6 is present in beta and alpha cells in human pancreatic islets: expression is reduced in subjects with type 1 diabetes","volume":"211","author":"Rajendran","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0755","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2014.02.002","article-title":"Beta-cell specific production of IL6 in conjunction with a mainly intracellular but not mainly surface viral protein causes diabetes","volume":"55","author":"Van Belle","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0760","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12916-020-1503-6","article-title":"Remission of autoimmune diabetes by anti-TCR combination therapies with anti-IL-17A or\/and anti-IL-6 in the IDDM rat model of type 1 diabetes","volume":"18","author":"J\u00f6rns","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0765","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.ajpath.2011.08.001","article-title":"IL-27 inhibits hyperglycemia and pancreatic islet inflammation induced by streptozotocin in mice","volume":"179","author":"Fujimoto","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0770","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1196\/annals.1375.024","article-title":"New members of the interleukin-12 family of cytokines: IL-23 and IL-27 modulate autoimmune diabetes","volume":"1079","author":"Mensah-Brown","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0775","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12860-023-00476-3","article-title":"Pre-treatment with IL-6 potentiates beta-cell death induced by pro-inflammatory cytokines","volume":"24","author":"Oliveira","year":"2023","journal-title":"BMC Mol Cell Biol"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0780","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.trim.2004.04.001","article-title":"IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo","volume":"13","author":"Choi","year":"2004","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0785","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.4049\/jimmunol.143.4.1188","article-title":"Evidence for IL-6 production by and effects on the pancreatic beta-cell","volume":"143","author":"Campbell","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0790","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00125-014-3249-1","article-title":"TLR2\/6 and TLR4-activated macrophages contribute to islet inflammation and impair beta cell insulin gene expression via IL-1 and IL-6","volume":"57","author":"Nackiewicz","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0795","first-page":"3367","article-title":"Production of TNF alpha, IL-1, IL-6 and nitric oxide by isolated human islets","volume":"27","author":"Vara","year":"1995","journal-title":"Transplant Proceed"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0800","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1096\/fj.201700061RR","article-title":"Interleukin 6 protects pancreatic beta cells from apoptosis by stimulation of autophagy","volume":"31","author":"Linnemann","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0805","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI0215841","article-title":"Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS","volume":"110","author":"Hong","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0810","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1096\/fj.201700710R","article-title":"Exercise training protects human and rodent beta cells against endoplasmic reticulum stress and apoptosis","volume":"32","author":"Paula","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0815","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.2337\/db17-1280","article-title":"Interleukin-6 reduces beta-cell oxidative stress by linking autophagy with the antioxidant response","volume":"67","author":"Marasco","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0820","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/153537020422900511","article-title":"Interleukin-11 inhibits NF-kappaB and AP-1 activation in islets and prevents diabetes induced with streptozotocin in mice","volume":"229","author":"Lgssiar","year":"2004","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0825","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1016\/j.celrep.2019.11.010","article-title":"Interleukin-27 is essential for type 1 diabetes development and Sjogren syndrome-like inflammation","volume":"29","author":"Ciecko","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0830","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9943","article-title":"Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression","volume":"8","author":"Hundhausen","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0835","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003444","article-title":"Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases","volume":"9","author":"Ferreira","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0840","article-title":"IL-6 receptor blockade does not slow beta cell loss in new-onset type 1 diabetes","volume":"6","author":"C.J. Greenbaum, E. Serti, K. Lambert, L.J. Weiner, S. Kanaparthi, S. Lord, S.E. Gitelman, D.M. Wilson, J.L. Gaglia, K.J. Griffin, W.E. Russell, P. Raskin, A. Moran, S.M. Willi, E. Tsalikian, L.A. DiMeglio, K.C. Herold, W.V. Moore, R. Goland, M. Harris, M.E. Craig, D.A. Schatz, D.A. Baidal, H. Rodriguez, K.M. Utzschneider, H.J. Nel, C.L. Soppe, K.D. Boyle, K. Cerosaletti, L. Keyes-Elstein, S.A. Long, R. Thomas, J.G. McNamara, J.H. Buckner, S. Sanda, I.A.E.S. Team","year":"2021","journal-title":"JCI insight"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0845","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3727\/096368913X667529","article-title":"Anakinra and tocilizumab enhance survival and function of human islets during culture: implications for clinical islet transplantation","volume":"23","author":"Sahraoui","year":"2014","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0850","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0855","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041120","article-title":"The relationship between type 1 diabetes mellitus, TNF-alpha, and IL-10 gene expression","volume":"11","author":"Dos Santos Haber","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0860","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clim.2016.08.004","article-title":"Changes of regulatory T cells, transforming growth factor-beta and interleukin-10 in patients with type 1 diabetes mellitus: A systematic review and meta-analysis","volume":"170","author":"Qiao","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0865","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.3892\/mmr.2017.7111","article-title":"Anti-CD20 monoclonal antibody combined with adenovirus vector-mediated IL-10 regulates spleen CD4+\/CD8+ T cells and T-bet\/GATA-3 expression in NOD mice","volume":"16","author":"Tang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0870","article-title":"Immunomodulation of streptozotocin induced type 1 diabetes mellitus in mouse model by macrophage migration inhibitory factor-2 (MIF-2) homologue of human lymphatic filarial parasite","volume":"252","author":"Singh","year":"2024","journal-title":"Wuchereria bancrofti, Acta Trop"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0875","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00007890-199710150-00017","article-title":"Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice","volume":"64","author":"Smith","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0880","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/intimm\/6.12.1927","article-title":"Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice","volume":"6","author":"Moritani","year":"1994","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0885","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.2337\/diabetes.48.10.1948","article-title":"T-cell production of an inducible interleukin-10 transgene provides limited protection from autoimmune diabetes","volume":"48","author":"Pauza","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0890","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","article-title":"The Immunobiology of the Interleukin-12 family: room for discovery","volume":"50","author":"Tait Wojno","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0895","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/jir.2021.0147","article-title":"Interleukin-35: structure, function and its impact on immune-related diseases","volume":"41","author":"Ye","year":"2021","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0900","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1331217","article-title":"IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy","volume":"15","author":"Krueger","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0905","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1006\/jaut.1996.0084","article-title":"Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice","volume":"9","author":"Rabinovitch","year":"1996","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0910","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1677\/joe.0.1580069","article-title":"Effects of interleukin-12 in vitro on pancreatic islets isolated from normal rodents and from non-obese diabetic mice","volume":"158","author":"Sternesjo","year":"1998","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0915","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/jaut.2000.0469","article-title":"IL-12 plays a pathologic role at the inflammatory loci in the development of diabetes in NOD mice","volume":"16","author":"Nitta","year":"2001","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0920","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.4049\/jimmunol.170.11.5491","article-title":"IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma","volume":"170","author":"Trembleau","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0925","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1172\/JCI200113915","article-title":"Constitutive beta cell expression of IL-12 does not perturb self-tolerance but intensifies established autoimmune diabetes","volume":"108","author":"Holz","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0930","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00125-012-2732-9","article-title":"Production and function of IL-12 in islets and beta cells","volume":"56","author":"Taylor-Fishwick","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0935","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142735","article-title":"Interleukin-12 (IL-12)\/STAT4 axis is an important element for beta-cell dysfunction induced by inflammatory cytokines","volume":"10","author":"Weaver","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0940","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/eji.200535325","article-title":"IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin","volume":"36","author":"Mensah-Brown","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0945","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12020-024-03753-z","article-title":"Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetes","volume":"85","author":"Luo","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0950","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.1038\/srep12633","article-title":"Interleukin-35 administration counteracts established murine type 1 diabetes--possible involvement of regulatory T cells","volume":"5","author":"Singh","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0955","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.4049\/jimmunol.1000462","article-title":"Type 1 diabetes in BioBreeding rats is critically linked to an imbalance between Th17 and regulatory T cells and an altered TCR repertoire","volume":"185","author":"van den Brandt","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0960","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2337\/db08-1113","article-title":"Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice","volume":"58","author":"Emamaullee","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109176","article-title":"NLRP1 acts as a negative regulator of Th17 cell programming in mice and humans with autoimmune diabetes","volume":"35","author":"Costa","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102708","article-title":"IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes","volume":"123","author":"Rajendran","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0975","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.2337\/db10-1643","article-title":"Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated beta-cell death","volume":"60","author":"Arif","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0980","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2014.05.002","article-title":"IL-32gamma overexpression accelerates streptozotocin (STZ)-induced type 1 diabetes","volume":"69","author":"Jhun","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0985","doi-asserted-by":"crossref","first-page":"D1040","DOI":"10.1093\/nar\/gks1215","article-title":"Interferome v2.0: an updated database of annotated interferon-regulated genes","volume":"41","author":"Rusinova","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbamcr.2026.120113_bb0990","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0092-8674(00)80047-1","article-title":"SOCS1 is a critical inhibitor of interferon \u03b3 signaling and prevents the potentially fatal neonatal actions of this cytokine","volume":"98","author":"Alexander","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2026.120113_bb0995","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3109\/08830185.2010.529976","article-title":"Pathogen recognition by the innate immune system","volume":"30","author":"Kumar","year":"2011","journal-title":"Intern Rev Immunol"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1000","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(87)91128-7","article-title":"Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus","volume":"2","author":"Foulis","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJM198508083130604","article-title":"In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis","volume":"313","author":"Bottazzo","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1010","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.2337\/dc10-2274","article-title":"Type 1 diabetes and interferon therapy: a nationwide survey in Japan","volume":"34","author":"Nakamura","year":"2011","journal-title":"Diab Care"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2169\/internalmedicine.39.146","article-title":"Type 1 diabetes mellitus caused by treatment with interferon-beta","volume":"39","author":"Kado","year":"2000","journal-title":"Intern. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1020","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(94)90276-3","article-title":"Onset of insulin-dependent diabetes mellitus after interferon-alfa therapy for hairy cell leukaemia","volume":"343","author":"Guerci","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1025","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1007\/s00125-016-4067-4","article-title":"Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes","volume":"59","author":"Richardson","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1030","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00125-017-4536-4","article-title":"IFN-\u03b1 induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells","volume":"61","author":"Coomans de Brach\u00e8ne","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1035","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nri3339","article-title":"NLRC5: a key regulator of MHC class I-dependent immune responses","volume":"12","author":"Kobayashi","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1040","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00125-016-4201-3","article-title":"Interferon-alpha mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes","volume":"60","author":"Marroqui","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1045","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1038\/s41467-020-16327-0","article-title":"An integrated multi-omics approach identifies the landscape of interferon-alpha-mediated responses of human pancreatic beta cells","volume":"11","author":"Colli","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2017.02.002","article-title":"Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress","volume":"80","author":"Lombardi","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1055","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.3389\/fimmu.2019.02900","article-title":"Molecular insight into the IRE1\u03b1-mediated type I interferon response induced by proteasome impairment in myeloid cells of the brain","volume":"10","author":"Studencka-Turski","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1060","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ni.1857","article-title":"TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages","volume":"11","author":"Martinon","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1065","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1210\/endo-117-5-2081","article-title":"Inhibitory effect of interferon on the production of insulin","volume":"117","author":"Shimizu","year":"1985","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1070","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd6527","article-title":"Group, islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes","volume":"7","author":"Apaolaza","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1075","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2337\/db11-0853","article-title":"Expression and regulation of chemokines in murine and human type 1 diabetes","volume":"61","author":"Sarkar","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1080","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00125-002-0879-5","article-title":"Serum concentrations of the interferon-gamma-inducible chemokine IP-10\/CXCL10 are augmented in both newly diagnosed type I diabetes mellitus patients and subjects at risk of developing the disease","volume":"45","author":"Nicoletti","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1085","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1507\/endocrj.K10E-076","article-title":"Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes","volume":"57","author":"Uno","year":"2010","journal-title":"Endocr. J."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1090","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn5732","article-title":"Transcription and splicing regulation by NLRC5 shape the interferon response in human pancreatic \u03b2 cells","volume":"8","author":"Szymczak","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1095","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.4049\/jimmunol.171.12.6838","article-title":"Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease","volume":"171","author":"Christen","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1100","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3389\/fendo.2020.00630","article-title":"Pancreatic alpha-cells contribute together with beta-cells to CXCL10 expression in type 1 diabetes","volume":"11","author":"Nigi","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1105","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1126\/science.8100367","article-title":"Induction of type I diabetes by interferon-alpha in transgenic mice","volume":"260","author":"Stewart","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1110","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0024-3205(98)00063-0","article-title":"Alpha interferon administration paradoxically inhibits the development of diabetes in BB rats","volume":"62","author":"Sobel","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1115","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1006\/jaut.1998.0203","article-title":"Low dose poly I:C prevents diabetes in the diabetes prone BB rat","volume":"11","author":"Sobel","year":"1998","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1120","doi-asserted-by":"crossref","first-page":"12439","DOI":"10.1073\/pnas.0806439105","article-title":"Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1125","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1073\/pnas.1700878114","article-title":"Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-\u03b1 signaling","volume":"114","author":"Marro","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1130","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nri1502","article-title":"Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes","volume":"4","author":"Roep","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fendo.2018.00051","article-title":"The role of NOD mice in type 1 diabetes research: lessons from the past and recommendations for the future","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-8227(96)01328-9","article-title":"Dominant TCR \u03b1-chain clonotypes and interferon-\u03b3 are expressed in the pancreas of patients with recent-onset insulin-dependent diabetes mellitus","volume":"34","author":"Yamagata","year":"1996","journal-title":"Diab Res Clin Pract"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633167","article-title":"Immune soluble factors in the cerebrospinal fluid of progressive multiple sclerosis patients segregate into two groups","volume":"12","author":"Donninelli","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1150","article-title":"IFN-\u03b3, should not be ignored in SLE","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1155","first-page":"77","article-title":"Effects of cytokines on rat pancreatic islet cell monolayer cultures: distinction between functional and cytotoxic effects on islet beta-cells","volume":"2","author":"Rabinovitch","year":"1989","journal-title":"Reg. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-024-0921-5_1","article-title":"H, regulation of IFN-\u03b3 expression","volume":"941","author":"Fenimore","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fimmu.2013.00112","article-title":"Epigenetic activation and silencing of the gene that encodes IFN-\u03b3","volume":"4","author":"Aune","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1170","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/cyto.1999.0528","article-title":"Correlation between DNA methylation and murine IFN-gamma and IL-4 expression","volume":"12","author":"Falek","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1175","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature05673","article-title":"Foxp3 controls regulatory T-cell function by interacting with AML1\/Runx1","volume":"446","author":"Ono","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1180","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1185","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/43213","article-title":"A new protein containing an SH2 domain that inhibits JAK kinases","volume":"387","author":"Endo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1190","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/imm.12362","article-title":"Clinical implications of interferon-\u03b3 genetic and epigenetic variants","volume":"143","author":"Smith","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1195","doi-asserted-by":"crossref","first-page":"12380","DOI":"10.1016\/S0021-9258(18)31401-7","article-title":"Interferon-gamma priming effects in the activation and deactivation of ISGF3 in K562 cells","volume":"268","author":"Gao","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009220","article-title":"Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses","volume":"17","author":"Feng","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1205","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1172\/JCI2899","article-title":"IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes","volume":"102","author":"Thomas","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1210","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1172\/JCI116859","article-title":"Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium","volume":"92","author":"H\u00e4nninen","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1215","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"Boehm","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1220","doi-asserted-by":"crossref","DOI":"10.4161\/jkst.23820","article-title":"The regulation of inflammation by interferons and their STATs","volume":"2","author":"Rauch","year":"2013","journal-title":"Jak-stat"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1225","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1073\/pnas.1018973108","article-title":"Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans","volume":"108","author":"Calderon","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1230","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1084\/jem.186.7.989","article-title":"Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice","volume":"186","author":"K\u00e4gi","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1235","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1084\/jem.185.3.531","article-title":"Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus","volume":"185","author":"von Herrath","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1240","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/intimm\/dxp097","article-title":"Critical role of IFN-\u03b3 in CFA-mediated protection of NOD mice from diabetes development","volume":"21","author":"Mori","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1245","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.4049\/jimmunol.172.9.5714","article-title":"Suppressor of cytokine Signaling-1 overexpression protects pancreatic \u03b2 cells from CD8+ T cell-mediated autoimmune Destruction1","volume":"172","author":"Chong","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1250","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110747","article-title":"Interferons limit autoantigen-specific CD8(+) T-cell expansion in the non-obese diabetic mouse","volume":"39","author":"Jhala","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1255","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41467-023-35948-9","article-title":"IFN\u03b3 signaling in cytotoxic T cells restricts anti-tumor responses by inhibiting the maintenance and diversity of intra-tumoral stem-like T cells","volume":"14","author":"Mazet","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1260","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/db16-0846","article-title":"Interferon-\u03b3 limits diabetogenic CD8+ T-cell effector responses in type 1 diabetes","volume":"66","author":"Driver","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1265","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1270","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/0006-291X(91)91630-U","article-title":"Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation","volume":"175","author":"Kr\u00f6ncke","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1275","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00125-006-0214-7","article-title":"Interferon-gamma potentiates endoplasmic reticulum stress-induced death by reducing pancreatic beta cell defence mechanisms","volume":"49","author":"Pirot","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1280","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2337\/diabetes.54.2.452","article-title":"Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells","volume":"54","author":"Cardozo","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1285","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/bbrc.2000.2402","article-title":"Interferon-dependent activation of the serine kinase PI 3\u2032-kinase requires engagement of the IRS pathway but not the stat pathway","volume":"270","author":"Uddin","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1290","doi-asserted-by":"crossref","first-page":"15938","DOI":"10.1074\/jbc.270.27.15938","article-title":"Interferon-alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3\u2032-kinase","volume":"270","author":"Uddin","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1295","first-page":"2434","article-title":"Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs","volume":"116","author":"Wang","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1300","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.4049\/jimmunol.158.11.5507","article-title":"Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice","volume":"158","author":"Vermeire","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1305","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0026-0495(99)90234-2","article-title":"Tumor necrosis factor alpha signaling pathway and apoptosis in pancreatic beta cells","volume":"48","author":"Ishizuka","year":"1999","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1310","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.4049\/jimmunol.179.5.2686","article-title":"Cutting edge: TNF-alpha-converting enzyme (TACE\/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock","volume":"179","author":"Horiuchi","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1315","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00125-008-0999-7","article-title":"Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role in pancreatic beta cells","volume":"51","author":"Ortis","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176157","article-title":"The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis","volume":"12","author":"Qiao","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1325","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-065X.1999.tb01302.x","article-title":"Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice","volume":"169","author":"Green","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1330","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.180.3.995","article-title":"Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process","volume":"180","author":"Yang","year":"1994","journal-title":"JExp Med"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1335","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1073\/pnas.87.3.968","article-title":"Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1","volume":"87","author":"Jacob","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1340","doi-asserted-by":"crossref","first-page":"12287","DOI":"10.1073\/pnas.172382999","article-title":"Tumor necrosis factor-\u03b1; regulation of CD4+ CD25+ T cell levels in NOD mice","volume":"99","author":"Wu","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1470677","article-title":"TNF-\u03b1 inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial","volume":"15","author":"Bazile","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1350","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1056\/NEJMoa2006136","article-title":"Golimumab and beta-cell function in youth with new-onset type 1 diabetes","volume":"383","author":"Quattrin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1355","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.4049\/jimmunol.139.12.4077","article-title":"Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity","volume":"139","author":"Mandrup-Poulsen","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1360","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1210\/endo.140.7.6873","article-title":"Tumor necrosis factor-\u03b1-activated cell death pathways in NIT-1 insulinoma cells and primary pancreatic \u03b2 cells*","volume":"140","author":"Stephens","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1365","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1128523","article-title":"Characterization of the functional and transcriptomic effects of pro-inflammatory cytokines on human EndoC-\u03b2H5 beta cells","volume":"14","author":"Fr\u00f8rup","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1370","series-title":"Transcription Regulation of Human Manganese Superoxide Dismutase Gene, Methods in Enzymology","first-page":"306","author":"St","year":"2002"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1375","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0896-8411(91)90025-8","article-title":"Cytotoxic effect of IFN-gamma plus TNF-alpha on human islet cells","volume":"4","author":"Soldevila","year":"1991","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1380","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.tp.0000234787.05789.23","article-title":"Tumor necrosis factor-alpha production by human islets leads to postisolation cell death","volume":"82","author":"Hanley","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1385","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143011","article-title":"Residual \u03b2 cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia","volume":"131","author":"Gubitosi-Klug","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1390","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/diabetes.53.1.250","article-title":"C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001","volume":"53","author":"Palmer","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1395","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(13)60023-9","article-title":"Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials","volume":"381","author":"Moran","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1400","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2337\/dc22-0908","article-title":"Two-year follow-up from the T1GER study: continued off-therapy metabolic improvements in children and young adults with new-onset T1D treated with golimumab and characterization of responders","volume":"46","author":"Rigby","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1405","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2337\/dc09-0054","article-title":"Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study","volume":"32","author":"Mastrandrea","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1410","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/acr.20657","article-title":"Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor alpha therapy","volume":"64","author":"Antohe","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1415","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2337\/dc08-2029","article-title":"Effect of ingested interferon-alpha on beta-cell function in children with new-onset type 1 diabetes","volume":"32","author":"Rother","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1420","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2337\/dc09-1349","article-title":"Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes","volume":"33","author":"Gottlieb","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1425","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/dom.14770","article-title":"Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trial","volume":"24","author":"Piemonti","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1430","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S2213-8587(21)00019-X","article-title":"Anti-interleukin-21 antibody and liraglutide for the preservation of \u03b2-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"von Herrath","year":"2021","journal-title":"The lancet. Diabetes & endocrinology"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1435","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2306691","article-title":"Baricitinib and \u03b2-cell function in patients with new-onset type 1 diabetes","volume":"389","author":"Waibel","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1440","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa2308743","article-title":"Teplizumab and \u03b2-cell function in newly diagnosed type 1 diabetes","volume":"389","author":"Ramos","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1445","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8980","article-title":"Type 1 diabetes TrialNet study, Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals","volume":"13","author":"Sims","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1450","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/CRD.0000000000000563","article-title":"Teplizumab therapy to delay the onset of type 1 diabetes","volume":"32","author":"Novograd","year":"2024","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.bbamcr.2026.120113_bb1455","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S2213-8587(24)00101-3","article-title":"Effect of population-wide screening for presymptomatic early-stage type 1 diabetes on paediatric clinical care","volume":"12","author":"Bonifacio","year":"2024","journal-title":"The lancet. Diabetes & endocrinology"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105734","article-title":"Pharmacological inhibition of tyrosine protein-kinase 2 reduces islet inflammation and delays type 1 diabetes onset in mice","volume":"117","author":"Syed","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbamcr.2026.120113_bb1465","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1126\/science.abi4742","article-title":"Preventing type 1 diabetes in childhood","volume":"373","author":"Dayan","year":"2021","journal-title":"Science"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:23:02Z","timestamp":1781943782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488926000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":293,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0167488926000091"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120113","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Friend or foe: New cytokine players in beta cell failure in type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120113"}}